Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Myelodysplastic Syndromes 4 Lymphoma, Non-Hodgkin 4 Leukemia, Myelomonocytic, Juvenile 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Hemoglobinuria, Paroxysmal 4 Carcinoma, Hepatocellular 3 Melanoma 2 Liver Diseases 2 Leukemia 2 Hodgkin Disease 2 Squamous Cell Carcinoma of Head and Neck 1 Neuroblastoma 1 Lymphoma 1 Liver Neoplasms 1 Histiocytosis 1 Hemoglobinuria 1 Colorectal Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 53 Etoposide 33 Temozolomide 28 Irinotecan 28 Melphalan 25 Filgrastim 25 Topotecan 24 Carboplatin 24 3-Iodobenzylguanidine 23 Isotretinoin 20 Granulocyte Colony-Stimulating Factor 17 sargramostim 16 humanized 3F8 anti-GD2 monoclonal antibody 16 dinutuximab 16 Granulocyte-Macrophage Colony-Stimulating Factor 16 fludarabine 15 Vincristine 15 Doxorubicin 15 Cisplatin 15 Peripheral Blood Stem Cell Transplantation 14 Interleukin-2 14 Busulfan 13 naxitamab 12 Thiotepa 12 Radiotherapy 12 aldesleukin 11 fludarabine phosphate 10 etoposide phosphate 8 Mesna 8 Ifosfamide 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neuroblastoma × Antibodies × Clear all

NCT02914405 2026-04-28

MiniVan

University Hospital Southampton NHS Foundation Trust

Phase 1 Active not recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡